MEHRAD ADIBI to Neoadjuvant Therapy
This is a "connection" page, showing publications MEHRAD ADIBI has written about Neoadjuvant Therapy.
Connection Strength
0.146
-
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2022 04; 20(2):176-182.
Score: 0.082
-
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol. 2012 Dec; 19(12):1060-6.
Score: 0.043
-
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23.
Score: 0.021